Su-Hyeong Kim Selected Research

diallyl trisulfide

1/2022	Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
6/2021	Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis.
3/2020	Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats.
6/2016	Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
6/2011	Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.
6/2010	Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su-Hyeong Kim Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 09/2004
25	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2010
11	Carcinogenesis 03/2020 - 09/2003
10	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 07/2009
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2010 - 09/2004
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2007
4	Adenocarcinoma 06/2020 - 06/2011
3	Ovarian Neoplasms (Ovarian Cancer) 06/2010 - 01/2007
2	Uterine Cervical Dysplasia 08/2009 - 08/2009
2	Vulvar Neoplasms (Vulvar Cancer) 08/2009 - 08/2009
1	Disease Progression 06/2020
1	Bone Resorption 01/2020
1	Prostatic Intraepithelial Neoplasia 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Triple Negative Breast Neoplasms 06/2016
1	Lymphoma (Lymphomas) 02/2015

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2006
10	withaferin AIBA 01/2021 - 08/2013
9	benzyl isothiocyanateIBA 01/2019 - 06/2010
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2006
6	diallyl trisulfideIBA 01/2022 - 06/2010
6	PhytochemicalsIBA 01/2022 - 09/2003
6	Celecoxib (Celebrex)FDA Link 08/2009 - 05/2004
5	Phenobarbital (Luminal)FDA Link 01/2022 - 03/2020
4	RNA (Ribonucleic Acid)IBA 06/2021 - 01/2019
4	sulforaphaneIBA 01/2020 - 07/2009
4	Small Interfering RNA (siRNA)IBA 03/2010 - 10/2006
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2009 - 05/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2009 - 05/2004
4	NF-kappa B (NF-kB)IBA 05/2009 - 09/2003
3	ChromatinIBA 01/2021 - 06/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 01/2009
3	LeptinIBA 03/2020 - 03/2011
3	Estrogen ReceptorsIBA 01/2020 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2011
3	LactonesIBA 01/2016 - 01/2014
3	phenethyl isothiocyanate (PEITC)IBA 08/2012 - 08/2010
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2009 - 09/2004
2	AndrogensIBA 06/2020 - 01/2018
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 08/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2010
2	CytokinesIBA 01/2017 - 01/2016
2	Epithelial Cell Adhesion MoleculeIBA 06/2016 - 08/2013
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2015 - 08/2012
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2013 - 08/2009
2	X-Linked Inhibitor of Apoptosis ProteinIBA 06/2011 - 06/2010
2	Androgen Receptors (Androgen Receptor)IBA 01/2011 - 07/2009
2	Oncogene Proteins (Oncogene Protein)IBA 12/2010 - 05/2009
2	Cisplatin (Platino)FDA LinkGeneric 08/2009 - 08/2009
2	GenisteinIBA 08/2009 - 08/2009
2	ParaffinIBA 08/2009 - 08/2009
2	ErbB Receptors (EGF Receptor)IBA 08/2009 - 01/2009
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2009 - 05/2004
2	Complementary DNA (cDNA)IBA 01/2007 - 10/2006
1	EnzymesIBA 01/2021
1	InterleukinsIBA 10/2020
1	Interleukin-8 (Interleukin 8)IBA 10/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2020
1	3,3',4,5'-tetrahydroxystilbeneIBA 06/2020
1	PolyphenolsIBA 06/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2020
1	Cyclin D1IBA 06/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2020
1	Ethanol (Ethyl Alcohol)IBA 05/2020
1	Conditioned Culture MediaIBA 01/2020
1	Diphosphonates (Bisphosphonates)IBA 01/2020
1	Lysosomal-Associated Membrane Protein 2IBA 01/2020
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	Denosumab FDA Link 01/2020
1	glucoraphaninIBA 01/2020
1	Lysosomal Membrane ProteinsIBA 01/2020
1	Kruppel-Like Factor 4IBA 01/2019
1	CateninsIBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2018
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2018
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2018
1	Acetyl-CoA CarboxylaseIBA 01/2018
1	dehydroabietylamineIBA 01/2017
1	Cytochromes c (Cytochrome c)IBA 01/2017
1	Caspase 9IBA 01/2017
1	Aldehyde Dehydrogenase 1 FamilyIBA 06/2016
1	Polycomb-Group ProteinsIBA 02/2015
1	TubulinIBA 01/2014
1	Cysteine (L-Cysteine)FDA Link 01/2014
1	Protein Isoforms (Isoforms)IBA 08/2013
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 08/2013

Therapy/Procedure

11	Chemoprevention 01/2021 - 12/2010
5	Therapeutics 01/2021 - 01/2007
2	Oral Administration 03/2020 - 01/2018
2	Ayurvedic Medicine (Siddha Medicine) 01/2017 - 08/2013
2	Drug Therapy (Chemotherapy) 11/2010 - 01/2007
1	Aftercare (After-Treatment) 01/2020
1	Castration 01/2018